Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Someya

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|July 21, 2025
Trends in good laboratory practice studies submitted for the marketing authorization of pharmaceuticals in JapanYusuke Oku, Hitoshi Someya
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2019
[Good Laboratory Practice: Initial Development, Necessity, and Issues of Data Reliability in Basic Research]Kanako Ito, Hitoshi Someya
Cancer Chemotherapy and Pharmacology|September 24, 2005
Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosineHitoshi Someya, William R Waud, William B Parker
Molecular Cancer Therapeutics|March 1, 2006
c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cellsJaideep V Thottassery, Louise Westbrook, Hitoshi Someya, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinaseHitoshi Someya, Sue C Shaddix, Kamal N Tiwari, et al.
Journal of Medicinal Chemistry|September 20, 2002
Enhancement of nucleoside cytotoxicity through nucleotide prodrugsJerry D Rose, William B Parker, Hitoshi Someya, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|July 21, 2025
Trends in good laboratory practice studies submitted for the marketing authorization of pharmaceuticals in JapanYusuke Oku, Hitoshi Someya
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 4, 2019
[Good Laboratory Practice: Initial Development, Necessity, and Issues of Data Reliability in Basic Research]Kanako Ito, Hitoshi Someya
Cancer Chemotherapy and Pharmacology|September 24, 2005
Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosineHitoshi Someya, William R Waud, William B Parker
Molecular Cancer Therapeutics|March 1, 2006
c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-D-arabinofuranosylcytosine-induced apoptosis in wild-type and p53-null colorectal cancer cellsJaideep V Thottassery, Louise Westbrook, Hitoshi Someya, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2003
Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinaseHitoshi Someya, Sue C Shaddix, Kamal N Tiwari, et al.
Journal of Medicinal Chemistry|September 20, 2002
Enhancement of nucleoside cytotoxicity through nucleotide prodrugsJerry D Rose, William B Parker, Hitoshi Someya, et al.
Pageof 1